Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

@article{Groll1997FluconazoleVN,
  title={Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.},
  author={Andreas H Groll and Gudrun Just-Nuebling and Maximilian Kurz and Carsten H. G. M{\"u}ller and Ulrike Nowak-G{\"o}ttl and Dirk Schwabe and Pramod M. Shah and Bernhard Kornhuber},
  journal={The Journal of antimicrobial chemotherapy},
  year={1997},
  volume={40 6},
  pages={855-62}
}
An open, prospective, randomized pilot study was performed to assess the efficacy and safety of oral fluconazole 3 mg/kg once daily compared with oral nystatin 50,000 units/kg/day in four divided doses in preventing candida infections in 50 children undergoing remission induction or consolidation therapy for cancer. In 21 of 25 fluconazole-treated and 20 of… CONTINUE READING